SC
BNGO icon

Sculptor Capital’s Bionano Genomics BNGO Stock Holding History

Sculptor Capital’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77
Closed -$28.1K – 427
2023
Q2 		$28.1K Buy
+77
New +$34.8K ﹤0.01% 315
2022
Q1 		– Sell
-676
Closed -$1.21M – 1230
2021
Q4 		$1.21M Hold
676
– – 0.01% 660
2021
Q3 		$2.23M Buy
676
+167
+33% +$584K 0.02% 461
2021
Q2 		$2.24M Buy
+509
New +$2.01M 0.02% 489

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sculptor Capital's BNGO Position: Q3 2023 in Review

Sculptor Capital sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 77 shares — an estimated $28.1K sold.

Sculptor Capital first reported a position in BNGO in Q2 2021 and held it in 4 quarters. The position peaked at $2.24M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Sculptor Capital reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Sculptor Capital sold 77 Bionano Genomics shares in Q3 2023, an estimated $28.1K.
  • Sculptor Capital first reported a position in Bionano Genomics in Q2 2021 and held it in 4 quarters.
  • Sculptor Capital's Bionano Genomics position peaked at $2.24M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Sculptor Capital's 13F filing for Q3 2023, filed 14 Nov 2023.